Search for content, post, videos

AstraZeneca vaccine trial paused after participant falls ill

Pascal Soriot
The Phase III clinical trials for a coronavirus vaccine, developed by AstraZeneca and Oxford University, have been paused after a participant had an adverse reaction in the UK. As part of the ongoing randomized, controlled clinical trials of the AstraZeneca Oxford coronavirus vaccine, AZD1222, a
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.